an overview of parp inhibitors in ovarian cancer
Published 4 years ago • 2.9K plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
6:44
parp inhibitors in advanced ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
6:54
current landscape of parp inhibition in ovarian cancer
-
5:13
practical use of parp inhibitors in ovarian cancer
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
1:58
parp inhibitor combinations and future of ovarian cancer
-
1:12
data demonstrate efficacy of 3 parp inhibitors in ovarian cancer
-
2:34
ovarian cancer: molecular testing and parp inhibitors
-
3:14
current and emerging roles of parp inhibition in ovarian cancer
-
4:14
parp inhibition in ovarian cancer: what’s next?
-
2:18
parp inhibition in recurrent ovarian cancer
-
1:07
challenges with parp inhibitors in ovarian cancer
-
2:31
toxicities associated with parp inhibitors in ovarian cancer
-
1:50
an overview of a study exploring mirvetuximab soravtansine in ovarian cancer
-
34:17
parp inhibitors for the treatment of ovarian cancer - gottfried konecny, md | uclamdchat
-
1:17
the complexity of the parp inhibitor landscape in ovarian cancer
-
4:17
case 2: olaparib in brca-mutated ovarian cancer
-
53:54
parp inhibitors in ovarian cancer treatment | webinar | ambry genetics
-
6:52
case 3: benefit of parp inhibitor maintenance in ovarian cancer